McGill-Queen's/Associated Medical Services Studies in the History of Medicine, Health, and Society

· · · · · · · · · · · · · · · · · · · ·
Latest release: February 15, 2023
Series
71
Books
Weariness, the Fever, and the Fret: The Campaign against Tuberculosis in Canada, 1900-1950
Book 8·Sep 1999
0.0
·
In The Weariness, the Fever, and the Fret Katherine McCuaig takes an in-depth look at the campaign against TB, from its beginnings as part of the turn-of-the-century urban social reform movement to the 1950s and the discovery of antibiotics that could cure it. Although the bacillus that causes it had been discovered in 1882, at the turn of the century TB was, as Osler observed, "a social disease with a medical aspect." With "fresh air, good food, good houses, and hope" as the only available treatment, fighting the disease meant not only eliminating the germ but attacking the underlying social problems that predisposed an individual to disease - alcoholism and poor living and working conditions. By the end of World War I the bacteriological approach had become dominant, with federally expanded sanatoria, increasing provincial involvement and responsibility, and more sophisticated technology to diagnose and treat the disease. The campaign against TB not only influenced the way in which health services were established and the division of responsibility among various levels of government and volunteers but profoundly affected attitudes toward the political and economic development of Canadian health care and the ultimate demand for medicare. Drawing on sources ranging from government reports and archival material to more general North American social and political historical research, McCuaig demonstrates how TB was viewed and how it was controlled, which owed as much to changing attitudes in society as to bacteriological discoveries.
Women, Health, and Nation: Canada and the United States since 1945
Book 16·Apr 2003
0.0
·
Authors provide a much-needed analysis of the dynamic decades after 1945, when both Canada and the United States began using federal funds to expand health-care access, and biomedical research and authority reached new heights. Focusing on a wide range of issues - including childbirth, abortion and sterilization, palliative care, pharmaceutical regulation, immigration, and Native health care - these essays illuminate the ironic promise of biomedicine, postwar transformations in reproduction, the varied work and belief-systems of female health-care providers, and national differences in women's health activism. Contributors include Aline Charles (Laval University), Barbara Clow (independent scholar), Laura E. Ettinger (Clarkson University), Georgina Feldberg (York University), Karen Flynn (York University), Vanessa Northington Gamble (Association of American Medical Colleges), Elena R. Gutiérrez (University of Illinois, Chicago), Molly Ladd-Taylor (York University), Alison Li (independent scholar), Maureen McCall (physician, Nepal), Michelle L. McClellan (University of Georgia), Kathryn McPherson (York University), Dawn Dorothy Nickel (University of Alberta), Heather Munro Prescott (Central Connecticut State University), Leslie J. Reagan (University of Illinois, Urbana-Champaign), Susan M. Reverby (Wellesley College), Susan L. Smith (University of Alberta), Ann Starr (visual artist and writer), and Judith Bender Zelmanovits (York University).
J.B. Collip and the Development of Medical Research in Canada: Extracts and Enterprise
Book 18·Oct 2003
0.0
·
In the early years of the twentieth century medical research in Canada was the job of a select few. By mid-century it had grown into a systematic, large-scale venture that involved teams of professional scientists and dozens of laboratories in universities, government, and industry. J.B. Collip - skilled both as a bench scientist and an entrepreneur - played a leading role in this transformation. In J.B. Collip and the Development of Medical Research in Canada Alison Li details how Collip leapt into prominence in 1921-22 as part of the team at the University of Toronto that isolated insulin. When the Nobel Prize was awarded to Frederick Banting and J.J.R. Macleod in 1923, Banting announced he was sharing his award with Charles Best; Macleod in turn announced he was sharing his award with Collip. Collip was known for his remarkable skills in making hormone extracts, many of which proved to have therapeutic, and therefore commercial, value. At McGill University in the 1930s he headed a thriving research group that carried out investigations of the pituitary and sex hormones, including development of one of the first orally active estrogen products. Collip's story sheds light on early negotiations between academic science and the pharmaceutical industry and on the complexities of sustaining a research laboratory before the rise of government funding. As the head of the National Research Council's medical research division during its formative years, Collip helped shape the foundations of organized support for medical research in Canada.
Ontario Cancer Institute: Successes and Reverses at Sherbourne Street
Book 19·Aug 2003
0.0
·
To achieve this goal the institute divided its operation into four strands: two of the strands were the research areas - the study of advanced radiation therapy and biology, which worked separatively but cooperatively; a third was patient care; and the fourth element was leadership, provided by the clinical chiefs, the heads of the research divisions, and the administration, in particular the institute's first administrator, John Law. Together these strands helped create a philosophy that made the Ontario Cancer Institute unique and provided the basis for its national and international success. Essential to these successes was a new graduate department, Medical Biophysics, based in the University of Toronto School of Graduate Studies. This department, which provided an innovative, research-based doctoral and masters program, meant that the OCI could accurately be described as a centre for cancer treatment, research, and education. McCulloch describes how the first quantitative assay for stem cells played a major role in bringing OCI research to the international stage as well as influencing other science and much of the clinical thinking in the Institute. Other major advances that brought international recognition have been the identification of the mechanisms that allow cancer cells to resist death from the effects of a variety of different tumours and the isolation of the gene that encodes the T cell receptor, a critical part of the immune apparatus for dealing with foreign cells and viruses. McCulloch also details how lack of space to meet growing demands was a continuing source of frustration and disagreement, and how sometimes serious interpersonal problems hindered the forward thrust of development. Describing these events as well as institute's successes, he provides an insight into the history of Canada's premier cancer research centre.